Pancreatic Cancer Research

ResearcherThe University of Texas Southwestern Medical CenterNo recent work listed

Francis J. Burrows

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0274-4911; OpenAlex author ID A5027112745. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper

Papers 3

  1. CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target. Last author DOI 10.3390/cancers14010086↗
  2. Cyclooxygenase-2 Inhibition Potentiates the Efficacy of Vascular Endothelial Growth Factor Blockade and Promotes an Immune Stimulatory Microenvironment in Prec… Co-author DOI 10.1158/1541-7786.mcr-18-0427↗
  3. Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-12-0453↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rolf A. Brekken · 3 shared papers, 2012–2021 · strength 0.33
  2. Shivani Malik · 1 shared paper, 2021 · strength 0.19
  3. Amanda Kirane · 2 shared papers, 2012–2019 · strength 0.14
  4. Noah B. Sorrelle · 1 shared paper, 2019 · strength 0.11
  5. Huocong Huang · 1 shared paper, 2019 · strength 0.11
  6. Yuqing Zhang · 1 shared paper, 2019 · strength 0.11
  7. Katherine T. Ostapoff · 1 shared paper, 2012 · strength 0.03
  8. Roderich Egbert Schwarz · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.